Innoser
InnoSer is a European preclinical CRO, working with well-characterized disease models, including induced and genetically engineered mouse models, spanning rare genetic diseases, neurology, immuno-oncology, and cardiometabolic disease.
InnoSer specializes in ADPKD, using the gold-standard Pkd1 knock-out mouse model originally developed by our academic collaborators. Since 2012, InnoSer has carried out a multitude of preclinical efficacy studies of small molecules, biologics and gene therapy candidates for ADPKD, providing translational data, helping guide our clients’ development programs.
